Cited by 110Hormonal and reproductive studiesAdrenal Hormones and DisordersAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency

Open access

Corrales, J J, Almeida, M, Burgo, R, Mories, M T, Miralles, J M, Orfao, A·2006·Journal of Endocrinology

DOI 10.1677/joe.1.06779

Open this paper in CoChat — free account Open PDF

Abstract

Androgens are considered to have immunomodulatory effects but their cellular mechanisms of action remain largely unknown. In the present study we prospectively analyzed the serial effects of androgen-replacement therapy on both the distribution of peripheral blood lymphocytes, monocytes and dendritic cells as well as on the production of interleukin (IL)-1β, IL-6 and tumor necrosis factor α (TNFα) inflammatory cytokines by circulating monocytes and CD33 myeloid, CD16 and plasmacytoid dendritic cell subsets, the most potent antigen-presenting cells (APCs) in type-2 diabetic men with partial androgen deficiency. Analyses were performed before therapy and at 1, 3, 6 and 12 months after treatment with 150 mg testosterone enanthate every 2 weeks in a group of 13 type-2 diabetic men. Our results show for the first time that testosterone-replacement therapy is associated with a reduction or complete abrogation of spontaneous ex vivo production of IL-1β, IL-6 and TNFα by APCs. Meanwhile, the in vitro production of inflammatory cytokines by these cells after stimulation with lipopolysaccharide plus recombinant human interferon-γ remained unchanged, suggesting that APCs preserve their constitutive machinery to produce inflammatory cytokines under androgen treatment. These results confirm and extend previous observations about the anti-inflammatory effects of androgen therapy on APCs in a new, previously unexplored model of androgen deficiency; namely, aging type-2 diabetic men. A decreased production of inflammatory cytokines by APCs might have important consequences for sex differences in susceptibility to autoimmune diseases, inflammatory response to injury and atheromatosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1677/joe.1.06779

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Hoskins, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Clinical and Experimental Immunology
Kay, H. (1966) · PubMed Central · Cited by 2,177
Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
The Journal of Investigative Dermatology
Kanof, N. M. (1967) · Archives of Dermatology · doi:10.1001/archderm.1967.01610020042010 · Cited by 1,372
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R., Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., & Ross, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3988 · Cited by 920
Effects of testosterone supplementation in the aging male
Tenover, J. S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1092 · Cited by 768
The Effect of Testosterone Replacement on Endogenous Inflammatory Cytokines and Lipid Profiles in Hypogonadal Men
Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031069 · Cited by 731

Show all 56 references

Sorted by citations

Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Testosterone deficiency, insulin resistance and the metabolic syndrome
Zitzmann, M. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.212 · Cited by 359
Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double‐blinded placebo‐controlled Moscow study
Kalinchenko, S. Y., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J., Giltay, E. J., & Saad, F. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03845.x · Cited by 348
The relationship between circulating testosterone and inflammatory cytokines in men
Mohamad, N.-V., Wong, S. K., Hasan, W. N. W., Jolly, J. J., Farhana, M. F. N., Ima-Nirwana, S., & Chin, K. (2018) · The Aging Male · doi:10.1080/13685538.2018.1482487 · Cited by 319
Testosterone: a vascular hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0582 · Cited by 301
The Anti-Inflammatory Effects of Testosterone
Bianchi, V. E. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00186 · Cited by 261
The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes
Kapoor, D., Clarke, S., Stanworth, R. D., Channer, K. S., & Jones, T. H. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0737 · Cited by 234
Testosterone deficiency: a risk factor for cardiovascular disease?
Jones, T. H. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.03.002 · Cited by 195
Androgen deficiency, diabetes, and the metabolic syndrome in men
Kalyani, R. R., & Dobs, A. S. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32814db856 · Cited by 173
Testosterone, cardiovascular disease and the metabolic syndrome
Corona, G., Rastrelli, G., Vignozzi, L., Mannucci, E., & Maggi, M. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.07.002 · Cited by 152
The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
Jones, T. H., & Saad, F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.016 · Cited by 153
Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence
Traish, A. M., Bolaños, J., Nair, S., Saad, F., & Morgentaler, A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120549 · Cited by 161
Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer
Ben-Batalla, I., Vargas-Delgado, M. E., von Amsberg, G., Janning, M., & Loges, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01184 · Cited by 149
“A study of men with partial androgen deficiency showed that testosterone replacement led to decreased ex vivo production of proinflammatory cytokines (79).”
Background
Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review
Saad, F., Aversa, A., M. Isidori, A., & J. Gooren, L. (2012) · Current Diabetes Reviews · doi:10.2174/157339912799424573 · Cited by 148
Neuroendocrine factors alter host defense by modulating immune function
Butts, C. L., & Sternberg, E. M. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.09.009 · Cited by 114
Testosterone and type 2 diabetes
Grossmann, M., Gianatti, E. J., & Zajac, J. D. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833919cf · Cited by 108
Why does COVID‐19 kill more elderly men than women? Is there a role for testosterone?
Papadopoulos, V., Li, L., & Samplaski, M. K. (2020) · Andrology · doi:10.1111/andr.12868 · Cited by 94
Skeletal myopathy in patients with chronic heart failure: significance of anabolic‐androgenic hormones
Josiak, K., Jankowska, E. A., Piepoli, M. F., Banasiak, W., & Ponikowski, P. P. (2014) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-014-0152-z · Cited by 93
Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
Jones, T. H. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00085.x · Cited by 91
Review: Testosterone and the metabolic syndrome
Muraleedharan, V., & Jones, T. H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810390258 · Cited by 98
The vulnerable man: impact of testosterone deficiency on the uraemic phenotype
Carrero, J. J., & Stenvinkel, P. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs383 · Cited by 90
Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016
Saitoh, M., Ishida, J., Doehner, W., von Haehling, S., Anker, M. S., Coats, A. J. S., Anker, S. D., & Springer, J. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.155 · Cited by 85
Androgen and Androgen Receptors as Regulators of Monocyte and Macrophage Biology in the Healthy and Diseased Lung
Becerra-Díaz, M., Song, M., & Heller, N. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01698 · Cited by 89
The Role of Testosterone in the Etiology and Treatment of Obesity, the Metabolic Syndrome, and Diabetes Mellitus Type 2
Saad, F., & Gooren, L. J. (2010) · Journal of Obesity · doi:10.1155/2011/471584 · Cited by 82
Sex‐specific and hormone‐related differences in vascular remodelling in atherosclerosis
Yerly, A., van der Vorst, E. P. C., Baumgärtner, I., Bernhard, S., Schindewolf, M., & Döring, Y. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13885 · Cited by 86
Randomized controlled trials – mechanistic studies of testosterone and the cardiovascular system
Jones, T. H., & Kelly, D. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_6_18 · Cited by 76
Androgens are bronchoactive drugs that act by relaxing airway smooth muscle and preventing bronchospasm
Montaño, L. M., Espinoza, J., Flores‐Soto, E., Chávez, J., & Perusquı́a, M. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0074 · Cited by 65
The role of testosterone in type 2 diabetes and metabolic syndrome in men
Saad, F. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000800002 · Cited by 64
Carcinogenesis induced by foreign bodies
Moizhess, T. G. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908070043 · Cited by 61
Testosterone and cardiovascular risk
Tirabassi, G., Gioia, A., Giovannini, L., Boscaro, M., Corona, G., Carpi, A., Maggi, M., & Balercia, G. (2013) · Internal and Emergency Medicine · doi:10.1007/s11739-013-0914-1 · Cited by 57
Do low testosterone levels contribute to the pathogenesis of asthma?
Cangüven, Ö., & Albayrak, S. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.01.006 · Cited by 56
Associations Among Hypogonadism, C-Reactive Protein, Symptom Burden, and Survival in Male Cancer Patients with Cachexia: A Preliminary Report
Fabbro, E. D., Hui, D., Nooruddin, Z. I., Dalal, S., Dev, R., Freer, G., Roberts, L., Palmer, J. L., & Bruera, E. D. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.09.021 · Cited by 55
Androgen Deficiency as a Predictor of Metabolic Syndrome in Aging Men
Kapoor, D., & Jones, T. H. (2008) · Drugs & Aging · doi:10.2165/00002512-200825050-00001 · Cited by 52
The Similarities and Differences between the Effects of Testosterone and DHEA on the Innate and Adaptive Immune Response
Buendía-González, F. O., & Legorreta‐Herrera, M. (2022) · Biomolecules · doi:10.3390/biom12121768 · Cited by 43
Hormonal effects on blood vessels
Akishita, M., & Yu, J. (2012) · Hypertension Research · doi:10.1038/hr.2012.4 · Cited by 41
Do androgens play any role in the physical frailty of ageing men?
O’Connell, M. D. L., Tajar, A., Roberts, S. A., & Wu, F. C. W. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01093.x · Cited by 39
Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
Saad, F. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2354 · Cited by 37
Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
Salciccia, S., Giudice, F. D., Eisenberg, M. L., Mastroianni, C. M., BERARDINIS, E. D., Ricciuti, G. P., Viscuso, P., Zingaropoli, M. A., Pasculli, P., Ciardi, M. R., et al. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211010105 · Cited by 38
Regulation of atherosclerotic plaque growth and stability by testosterone and its receptor via influence of inflammatory reaction
Li, S., Li, X., & Li, Y. (2008) · Vascular Pharmacology · doi:10.1016/j.vph.2008.03.004 · Cited by 36
Androgen Deprivation Therapy Impact on Quality of Life and Cardiovascular Health, Monitoring Therapeutic Replacement
Trost, L. W., Şerefoğlu, E. C., Gökçe, A., Linder, B. J., Sartor, A. O., & Hellstrom, W. J. G. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12036 · Cited by 35
Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer’s Disease: Testosterone as a Modifier
Asih, P. R., Tegg, M., Sohrabi, H. R., Carruthers, M. E., Gandy, S., Saad, F., Verdile, G., Ittner, L. M., & Martins, R. N. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161259 · Cited by 34
Effects of Sex Steroids on Innate and Adaptive Immunity
Ahmed, S. A., Karpuzoglu, E., & Khan, D. (2009) · Springer eBooks · doi:10.1007/978-3-642-02155-8_2 · Cited by 35
A review on the interactions between the tumor microenvironment and androgen receptor signaling in prostate cancer
McAllister, M. J., Underwood, M. A., Leung, H. Y., & Edwards, J. (2018) · Translational research · doi:10.1016/j.trsl.2018.11.004 · Cited by 33
Testosterone treatment longer than 1 year shows more effects on functional hypogonadism and related metabolic, vascular, diabetic and obesity parameters (results of the 2-year clinical trial)
Antonič, K. G., Antonič, B., Žuran, I., & Pfeifer, M. (2020) · The Aging Male · doi:10.1080/13685538.2020.1793132 · Cited by 33
Endocrine alterations and cardiovascular risk in CKD: is there a link?
Ros, S., & Carrero, J. J. (2013) · PubMed · doi:10.3265/nefrologia.pre2012.oct.11710 · Cited by 32
Late‐onset hypogonadism: Reductio ad absurdum of the cardiovascular risk‐benefit of testosterone replacement therapy
Sesti, F. F., Pofi, R., Minnetti, M., Tenuta, M., Gianfrilli, D., & Isidori, A. M. (2020) · Andrology · doi:10.1111/andr.12876 · Cited by 31
Enhanced immunological response by dendritic cells in male hypogonadism
Hernández, J. J. C., Almeida, M. D. G., Cordero, M., Martín‐Martín, L., Méndez, C., Miralles, J. M., & Órfão, A. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02712.x · Cited by 31
Self-citation
Sex—the most underappreciated variable in research: insights from helminth-infected hosts
Wesołowska, A. (2022) · Veterinary Research · doi:10.1186/s13567-022-01103-3 · Cited by 33
Persistence of androgenic effects on the production of proinflammatory cytokines by circulating antigen-presenting cells after withdrawal of testosterone treatment in aging type 2 diabetic men with partial androgen deficiency
Hernández, J. J. C., Almeida, M. D. G., Miralles, J. M., & Órfão, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.05.040 · Cited by 29
Self-citation
Testosterone inhibits aneurysm formation and vascular inflammation in male mice
Son, B., Kojima, T., Ogawa, S., & Akishita, M. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0646 · Cited by 28
Is androgen deprivation therapy for prostate cancer associated with cardiovascular disease? A meta‐analysis and systematic review
Liang, Z. C., Zhu, J. W., Duo, X., Shi, S., Xu, Y., Yang, Y., Hu, R., Lu, Y., Zhang, W., Ou, N., et al. (2019) · Andrology · doi:10.1111/andr.12731 · Cited by 28
Androgen receptor moonlighting in the prostate cancer microenvironment
Cioni, B., Zwart, W. T., & Bergman, A. M. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0042 · Cited by 27
Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer
Corona, G., Filippi, S., Bianchi, N., Dicuio, M., Rastrelli, G., Concetti, S., Sforza, A., & Maggi, M. (2020) · The World Journal of Men s Health · doi:10.5534/wjmh.200109 · Cited by 27
Relationship between insulin and hypogonadism in men with metabolic syndrome
Caldas, A. D. A., Porto, A. L. A., da Motta, L. D. C., & Casulari, L. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000800015 · Cited by 25
The Effects of Testosterone Deficiency and Its Replacement on Inflammatory Markers in Rats: A Pilot Study
Chin, K., & Ima-Nirwana, S. (2017) · Intern J Endocrinol Metab · doi:10.5812/ijem.43053 · Cited by 24
ALPK1 affects testosterone mediated regulation of proinflammatory cytokines production
Kuo, T., Yeh, K., Hsu, H., Chiang, S., Chang, J., Huang, C., Tu, H., Liu, C.-S., & Ko, Y. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.08.007 · Cited by 24
Exploring the role of sex hormones and gender diversity in multiple sclerosis
Nesbitt, C., van der Walt, A., Butzkueven, H., Cheung, A. S., & Jokubaitis, V. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01042-x · Cited by 23
Testosterone therapy and prostate cancer
Pastuszak, A. W., Rodríguez, K. M. G., Nguyen, T. M., & Khera, M. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.08.17 · Cited by 23
The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts
Kırlangıç, O. F., Yilmaz‐Oral, D., Kaya‐Sezginer, E., Toktanis, G., Tezgelen, A. S., Sen, E., Khanam, A., Öztekin, Ç. V., & Gür, S. (2020) · Sexual Medicine · doi:10.1016/j.esxm.2020.02.006 · Cited by 23
Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial
Pedersen, L., Christensen, L. L., Pedersen, S. S., & Andersen, M. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0597-3 · Cited by 20
Influence of Gestational Hormones on the Bacteria‐Induced Cytokine Response in Periodontitis
Ortiz‐Sánchez, B. J., Legorreta‐Herrera, M., & Rodríguez‐Sosa, M. (2021) · Mediators of Inflammation · doi:10.1155/2021/5834608 · Cited by 18
Testosterone stimulates cholesterol clearance from human macrophages by activating LXRα
Kilby, E., Kelly, D. M., & Jones, T. H. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119040 · Cited by 17
The role of the urologist in the prevention and early detection of cardiovascular disease
Yassin, A. A., Saad, F., Haider, A., & Gooren, L. J. (2011) · Arab Journal of Urology · doi:10.1016/j.aju.2011.03.014 · Cited by 16
Abuse of Anabolic-Androgenic Steroids and Adverse Effects on Human Organ Health: A Review
(2022) · Biointerface Research in Applied Chemistry · doi:10.33263/briac133.281 · Cited by 16
Effects of Transdermal Testosterone Tretment on Inflammatory Markers in Elderly Males
Maggio, M. G., Snyder, P. J., Vita, F. D., Ceda, G. P., Milaneschi, Y., Lauretani, F., Luci, M., Cattabiani, C., Peachey, H., Valenti, G., et al. (2014) · Endocrine Practice · doi:10.4158/ep13357.or · Cited by 16
Hypogonadism in men with type 2 diabetes
Jones, T. H. (2007) · Practical Diabetes · doi:10.1002/pdi.1117 · Cited by 15
“Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”
Hanna, D. J., Jamieson, S. T., Lee, C. S., Pluskota, C. A., Bressler, N., Benotti, P. N., Khurana, S., Rolston, D. D. K., & Still, C. D. (2021) · Obesity Science & Practice · doi:10.1002/osp4.509 · Cited by 14
Novel androgen therapies including selective androgen receptor modulators
Kang, J., Chen, R., Tharakan, T., & Minhas, S. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101686 · Cited by 15
Testosterone, obesity, diabetes and the metabolic syndrome
Jones, T. H., & Channer, K. S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.012 · Cited by 13
Men, testosterone and Covid‐19
Antonič, K. G., Antonič, B., Caliber, M., & Dhindsa, S. (2023) · Clinical Endocrinology · doi:10.1111/cen.14952 · Cited by 12
Testosterone replacement therapy in hypogonadal men is associated with increased expression of LAMP ‐2 ( CD 107b) by circulating monocytes and dendritic cells
Hernández, J. J. C., Almeida, M. D. G., Martín‐Martín, L., Miralles, J. M., & Orfao, A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12338 · Cited by 12
Self-citation
Administration of testosterone to elderly hypogonadal men with Crohn's disease improves their Crohn's Disease Activity Index: a pilot study
Haider, A., Kurtz, W., Giltay, E. J., Gooren, L. J., & Saad, F. (2010) · hmbci · doi:10.1515/hmbci.2010.033 · Cited by 10
Endocrine Immune Interactions in the Host-Parasite Relationship: Steroid Hormones as Immune Regulators in Parasite Infections
Aguilar Díaz, H., & Nava Castro, K. E. (2015) · Journal of Steroids & Hormonal Science · doi:10.4172/2157-7536.1000165 · Cited by 9
Vascular Dysfunction among Malaysian Men with Increased BMI: An Indication of Synergistic Effect of Free Testosterone and Inflammation
Aminuddin, A., Salamt, N., Fuad, A. F. A., Chin, K., Ugusman, A., Soelaiman, I. N., & Ngah, W. Z. W. (2019) · Medicina · doi:10.3390/medicina55090575 · Cited by 7
ORIGINAL ARTICLE: Gender Dimorphism of Macrophage Response to GMCSF and IL‐4 for Differentiation into Dendritic Cells
Gupta, V., & Singh, S. M. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2008.00589.x · Cited by 8
Androgens’ Role in Severity and Mortality Rates of COVID-19
Ataei, A., Derakhshan, M. M., Razmjooie, M., Zare, F., Amiresmaeili, H., Salehi, N., Namakkoobi, N., Mirhosseini, H., Karim, B., & Iravani, S. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1954-5605 · Cited by 6
Role of olfactory reactions, nociception, and immunoendocrine shifts in addictive disorders
Мастерова, Е. И., Невидимова, Т. И., Савочкина, Д. Н., Nikitina, V. B., Лобачева, О. А., Vetlugina, T. P., & Bokhan, N. A. (2017) · American Journal on Addictions · doi:10.1111/ajad.12580 · Cited by 6
Immunobiology of Dendritic Cells in Cancer
Shurin, M. R., Keskinov, A. A., & Chatta, G. S. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8056-4_5 · Cited by 6
Covid-19’da Cinsiyet Hormonlarının İmmün Yanıt Üzerine Etkileri
Yılmaz, A., Kaçaroğlu, D., Atıcı, Y., & AYDAŞ, H. Ş. (2021) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.1003159 · Cited by 5
Testosterone and cardiovascular disease
Channer, K. S., & Jones, T. H. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.011 · Cited by 5
The immune and metabolic treatment approach of using testosterone on mice models of liver injury
Amer, J., Salhab, A., Snobar, H., & AlHabil, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1219709 · Cited by 4
Study the Biochemical Correlation of Insulin Resistance with HbA1c and Sex Hormones in NIDDM Patients/Meisan-Iraq
Al‐Fartosy, A. J. M., & Mohammed, I. M. (2017) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2017.74025 · Cited by 4
Testosterone Replacement Therapy in Athletes: Implications for Injury Recovery and Musculoskeletal Performance
de Velasco, L. M. C., Flores, J. E. G., Cervera, A. A., Arteaga, J. L. M., & Casas, M. J. O. (2026) · Cureus · doi:10.7759/cureus.103530 · Cited by 3
Testosterone Replacement Therapy as a Potential Strategy to Preserve Lean Mass in Men With Persistently Low Serum Testosterone Receiving GLP-1 Receptor Agonists: A Narrative Review
de Velasco, L. M. C., Flores, J. E. G., Kraus-Fischer, G., Arteaga, J. L. M., Casas, M. J. O., Nava, K. N. A., & Morales, F. M. M. (2026) · Cureus · doi:10.7759/cureus.105734 · Cited by 3
Immunobiology of Dendritic Cells in Cancer
Shurin, M. R., & Chatta, G. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-69118-3_6 · Cited by 3
Inflammation in Chronic Kidney Disease
Cobo, G., Jankowska, M., Stenvinkel, P., & Lindholm, B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52978-5.00014-8 · Cited by 2
Testosterone moderates the effects of social support on cardiovascular disease risk factors among older US men
Gettler, L. T., Sarma, M. S., Gengo, R. G., Oka, R., & McKenna, J. J. (2019) · American Journal of Human Biology · doi:10.1002/ajhb.23248 · Cited by 2
Influence of testosterone on purine metabolism and gout
Паневин, Т. С. (2021) · Andrology and Genital Surgery · doi:10.17650/1726-9784-2021-22-3-11-17 · Cited by 2
Testosterone replacement and cardiovascular disease risk
Gonzalez, J. R., & Goldstein, I. (2015) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000051 · Cited by 2
Hormone Replacement Therapy with Testosterone
Bassas, L., & Resmini, E. (2013) · Springer eBooks · doi:10.1007/978-3-642-37393-0_173-1 · Cited by 1
Sex matters: mechanistic insights into sex-driven patterns of autoimmunity and implications for pharmacotherapy
Guedes, M. S., & Yildiz, D. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-04990-x · Cited by 3
Sex differences in innate immune cell responses: Impact on cancer immunity and response to therapy
Ramin, S., & Medler, T. R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1864861 · Cited by 1
Dynamic Stabilization Exercises Leg Press and Single Leg Straight Deadlift with Medicine Ball Can Im-prove Leg Muscle Strength and Balance
Bana, P., Nurhasan, N., Kristiyandaru, A., Kusnanik, N. W., Turi, M., & Ayubi, N. (2024) · Retos · doi:10.47197/retos.v54.101466 · Cited by 2
Dendritic Cells in the Tumor Microenvironment
Shurin, M. R., & Keskinov, A. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.17014-6 · Cited by 1
Hormone Replacement Therapy with Testosterone and the Vascular System
Bassas, L., & Resmini, E. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_173
Age differences in Glucocorticoid Sensitivity of Inflammatory Cytokine Production Before and After stress
Ha, K. (2014) · Brandeis Institutional Repository
Relationship between insulin and hypogonadism in men with metabolic syndrome Relação entre insulina e hipogonadismo em homens com síndrome metabólica
Caldas, A. D. A., Porto, A. L. A., Domingues, L., da Motta, C., & Casulari, L. A. (2009)
Causas y consecuencias del hipogonadismo en varones con diabetes mellitus tipo 2
Ruiz, A. H. (2015) · Gredos (University of Salamanca) · doi:10.14201/gredos.128430
Study of the relation between serum testosterone level and carotid atherosclerosis in elderly men
Gayar, N. H. E., Mahmoud, M., & Elabd, A. (2015) · Egyptian Journal of Obesity Diabetes and Endocrinology · doi:10.4103/2356-8062.178324
Androgensubstitution des älteren Mannes
Jockenhövel, F. (2010) · Elsevier eBooks · doi:10.1016/b978-3-437-24680-7.10050-9

Authors: Corrales, J. J., Almeida, M., Burgo, R., Mories, M. T., Miralles, J. M., & Orfao, A.
Affiliations: Universidad de Salamanca (ES)
Complejo Hospitalario de Salamanca (ES)
ORCID: Almeida, M
Mories, M T
Venue: Journal of Endocrinology
Publisher: Bioscientifica
Published: 2006-06
Volume: 189
Issue: 3
Pages: 595-604
ISSN: 0022-0795 (ISSN-L)
1479-6805
DOI: 10.1677/joe.1.06779
OpenAlex: W2139503270
Cited by: 110
References: 56
Citations by year: 2026: 5 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 9 · 2017: 5 · 2016: 3 · 2015: 6 · 2014: 5 · 2013: 6 · 2012: 8
FWCI: 4.08
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Endocrinology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: testosterone replacement therapy, testosterone enanthate, androgen deficiency, type 2 diabetes, older men, antigen-presenting cells, dendritic cells, monocytes, inflammatory cytokines, IL-1β, interleukin-6, TNF-α, immunomodulation, atheromatosis
MeSH terms: Aged, Androgens, Anti-Inflammatory Agents, Antigen-Presenting Cells, Depression, Chemical, Diabetes Mellitus, Type 2, Humans, Interleukin-1, Lymphocytes, Male, Middle Aged, Testosterone, Tumor Necrosis Factor-alpha, Interleukin-6, Case-Control Studies, Lymphocyte Subsets, Cytokines, Lymphocyte Count, Statistics, Nonparametric, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks